Medtronic (MDT) Equity Average (2014 - 2026)

Medtronic's Equity Average history runs 13 years deep, the most recent figure standing at $49.0 billion for Q1 2026.

• In Q1 2026, Equity Average changed 0.28% year-over-year to $49.0 billion; the TTM figure through Jan 2026 stood at $49.0 billion (changed 0.28% YoY), while the FY2025 annual figure was $49.3 billion, down 3.34% from the prior year.
• Equity Average came in at $49.0 billion for Q1 2026 at Medtronic, up from $48.5 billion in the prior quarter.
• In the past five years, Equity Average ranged from a high of $52.8 billion in Q3 2022 to a low of $48.2 billion in Q3 2025.
• A 5-year average of $50.7 billion and a median of $51.5 billion in 2023 frame the typical range for Equity Average.
• Across the five-year window, Equity Average climbed 3.58% in 2022 and slipped 5.96% in 2024, its largest moves.
• Medtronic's Equity Average stood at $52.4 billion in 2022, then retreated by 1.8% to $51.5 billion in 2023, then retreated by 5.96% to $48.4 billion in 2024, then grew by 0.12% to $48.5 billion in 2025, then advanced by 1.1% to $49.0 billion in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $49.0 billion, $48.5 billion, and $48.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison